Prescription drug monitoring programs (PDMPs), state-run electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients, are important tools for preventing and identifying prescription drug misuse. By tracking the dispensing of these substances through patient reports, both prescribers and dispensers can identify patterns that might indicate that a patient is misusing, abusing, or diverting prescription drugs. Further, PDMP data can assist prevention and treatment program planning. However, PDMPs work only if prescribers and dispensers use them regularly.
PDMPs continuously adopt new strategies and take advantage of the latest technology in order to better respond to new prescription abuse and misuse challenges. To increase utilization of the PDMP by health-care providers, the majority of PDMPs initiated mandatory registration of prescribers and/or dispensers, as well as mandatory queries by certain health-care professionals. Most PDMPs also require that additional data elements, such as method of payment and identification of the person picking up the medication, be reported to the PDMP.
Efforts to strengthen prescriber and dispenser utilization of PDMPs include outreach and training to understand the value and application of PDMP data, improving prescription data accessibility and workflows through data integration, and implementing procedures to increase the accuracy and timeliness of data.
COAP supports activities that:
COAP grantees strengthening the nation’s Prescription Drug Monitoring Programs
The Connecticut Prescription Monitoring Program (PMP), in partnership with other state agencies, will merge the Office of the Chief Medical Examiner (OCME) and the state forensic laboratory system with the Connecticut Prescription Monitoring and Reporting System (CPMRS) to allow prescribers and pharmacists to identify patients who have died and reduce inappropriate dispensing; create a new module to allow law enforcement users access to both death data and toxicology information within the CPMRS to assist in their investigations; and conduct educational campaigns to introduce these new features and the benefits that would expand the ability of prescribers, pharmacists, and law enforcement to avoid and deter controlled substance misuse or diversion.
Guam’s Department of Public Health and Social Services will enhance and improve data analysis by upgrading to the AWARxE Advanced Prescription Monitoring Program analytics. Guam will also partner with the Commonwealth of the Northern Mariana Islands to increase the capability of public and private pharmacies to report prescription information to the Guam Prescription Drug Monitoring Program (PDMP).
The Nebraska Department of Health and Human Services Division of Public Health will add provider dashboard enhancements to the Nebraska Prescription Drug Monitoring Program (PDMP) that support clinical decision making. The Division of Public Health will also develop updated training for prescribers, dispensers, and designees on the provider dashboard enhancements and produce updated training videos.